Successful off-label therapy of advanced cutaneous angiosarcomas with ipilimumab and nivolumab after failure of conventional treatment approaches.

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Simon Goller; Matthias Goebeler; Valerie Glutsch; Ugur Uslu; Anja Gesierich; Jan Hendrik Maiwald; Magdalena-Sophie Greiner

Sep 7, 2026